birskdd.ru


CPRX PRICE TARGET

Catalyst Pharmaceuticals stock price target raised to $17 from $12 at Truist. Aug. 11, at a.m. ET by Tomi Kilgore. Read full story. Fintech Companies. Stock Price Forecast. The 6 analysts with month price forecasts for CPRX stock have an average target of , with a low estimate of 23 and a high estimate. CPRX is currently covered by 6 analysts with an average price target of $ This is a potential upside of $ (%) from yesterday's end of day. Catalyst Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CPRX updated stock price target summary. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

Free Catalyst Pharmaceuticals (CPRX) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions. Analyst Price Targets ; ; Average ; Current ; High. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ 10 Top Catalyst Pharmaceuticals CPRX Share price target (tomorrow) | 10 top stock Price (target) Catalyst Pharmaceuticals CPRX NASDAQ. Find the latest Catalyst Pharmaceuticals Inc (CPRX) stock forecast, month price target, predictions and analyst recommendations. Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock, Analyst Ratings, Price Targets, Forecasts Catalyst Pharmaceuticals Inc has a consensus price target of $ View Catalyst Pharmaceuticals, Inc. CPRX stock quote prices, financial information, real-time forecasts, and company news from CNN. Catalyst Pharmaceuticals CPRX share price forecast & targets for Intra Day are , , on the downside, and , , on the upside. Wall St. Analysts' Avg. Rating History. 1M; 6M; 1Y; 3Y. Go Premium to see CPRX Wall St. Analysts' Rating. Subscribe Now. CPRX Price Target. Price Target vs. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ CPRX will report FY earnings on 03/12/ Yearly Estimates. According to our current Crypto Perx price prediction, the price of Crypto Perx is predicted to rise by % and reach $ by August 14,

Catalyst Pharmaceuticals (CPRX) stock price prediction is USD. The Catalyst Pharmaceuticals stock forecast is USD for According to 6 Wall Street analysts that have issued a 1 year CPRX price target, the average CPRX price target is $, with the highest CPRX stock price. According to analysts, CPRX price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. The average stock forecast for Catalyst Pharmaceuticals Inc (CPRX) is USD. This price target corresponds to an upside of %. According to our current CPRX stock forecast, the value of Catalyst Pharmaceuticals shares will rise by % and reach $ per share by September 3, Catalyst Pharmaceuticals Stock Forecast, CPRX stock price prediction. Price target in 14 days: USD. The best long-term & short-term Catalyst. Catalyst Pharma Stock Smart Score ; Analyst Consensus. Strong Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. CPRX Sentiment %. According to the 6 analysts' twelve-month price targets for Catalyst Pharmaceuticals, the average price target is $ The highest price target for CPRX is. According to 6 analysts, the average rating for CPRX stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the.

The current projected Catalyst Pharmaceuticals target price consensus is with 7 analyst opinions. The most common way Catalyst Pharmaceuticals analysts. Lowering target price to $ CATALYST PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $; an Industry Subrating of Low; a. Analysts' recommendations: Catalyst Pharmaceuticals, Inc. · Truist Adjusts Price Target on Catalyst Pharmaceuticals to $30 From $25, Maintains Buy Rating. The Catalyst Pharmaceuticals Inc (CPRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $ CATALYST PHARMACEUTICALS INC (CPRX) Price Targets From Analysts ; , 5, $12, $7, $ ; , 5, $12, $7, $

CPRX Stock (Catalyst Pharmaceuticals stock) CPRX STOCK PREDICTIONS! CPRX STOCK Analysis CPRX news

12 analyst ratings ; Truist Securities. Joon Lee. 52% accuracy. 45 / 87 met price target. 62%upside. $ Buy. Maintained. 9 Aug ; Oppenheimer. Leland. Wall Street analysts forecast CPRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CPRX is. the latest Catalyst Pharmaceuticals, Inc CPRX detailed stock quotes, stock *Price Target & Stock Forecast · Full Company Report · Earnings Dates and. Earnings for Catalyst Pharmaceuticals are expected to grow by % in the coming year, from $ to $ per share. Price to Earnings Ratio vs. the Market. Exchange. NASDAQ-CM ; Sector. Health Care ; Industry. Biotechnology: Pharmaceutical Preparations ; 1 Year Target. $ ; Today's High/Low. $/$ Discover Catalyst Pharmaceuticals' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry.

S&P Technology Index | Retail Ticketing System

7 8 9 10 11


Copyright 2012-2024 Privice Policy Contacts SiteMap RSS